Federal Agency · Defense Health Agency Contracting Activity - DHACA
DoW Neurofibromatosis Research Academy – Scholar Award
Last updated: September 6, 2026
Posted June 25, 2026
Funding
Funding amount not specified
Closes
September 22, 2026
NAICS
541715
Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Neurofibromatosis Research Academy – Scholar Award (NFRA-SA) supports early-career independent investigators (Scholars) joining the Neurofibromatosis Research Academy to pursue a neurofibromatosis project that may include basic, translational, and/or clinical research. The proposed research should address at least one of the FY26 NFRP Areas of Emphasis, under the leadership of the NFRA Director and Deputy Director. The overarching goal of the NFRA is to conduct innovative and impactful research in the field of neurofibromatosis disorders while developing successful, highly productive NF researchers in a collaborative research and career development environment. Distinctive Features: • Scholar: The Scholar, named as the Principal Investigator, must be less than 10 years of completion of their terminal degree by the time of the application deadline (excluding time spent in residency, clinical training, or on family medical leave). • Career Guide: This award mechanism requires each Scholar to designate a Career Guide for guidance. The Career Guide is not required to be at the same institution as the Scholar; however, if the (primary) Career Guide is from a different institution, the application must identify a secondary Career Guide at the Scholar’s institution.
Eligibility
- Funded by DoD-generic
Award details
Applications close on September 22, 2026 (15 days remaining).
Categories
Environment Energy
Sign up at GrantRegister to see if this grant matches your organization.
Match my organization →View application on Grants.gov →·Source: Grants.gov·Last seen Sep 6, 2026
Similar grants
- Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)National Institutes of Health · closes September 7, 2026
- Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)National Institutes of Health · closes September 7, 2026
- Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed)National Institutes of Health · closes September 7, 2026
- Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)National Institutes of Health · closes September 7, 2026
- Tribal Wildfire Resilience Grants Solicitation 2026Department of Forestry and Fire Protection · closes September 8, 2026
- A Science of Science Approach to Analyzing and Innovating the Biomedical Research EnterpriseU.S. National Science Foundation · closes September 9, 2026
- Public Wireless Supply Chain Innovation Fund Grant Program – Solutions for AI-Native RANNational Telecommunications and Information Admini · closes September 9, 2026
- The Wege Foundation — Education, Environment, Arts & Culture, Community Health & Wellbeing GrantsThe Wege Foundation · closes September 9, 2026
